NICE recommends Eli Lilly’s treatment for early-stage breast cancer

The National Institute for Health and Care Excellence (NICE) recommends abemaciclib (also known as Verzenios) for patients undergoing surgery for early-stage breast cancer at high risk of recurrence with hormone receptor positive, HER2-negative, and lymph node metastasis positive. Announced. To get rid of their tumors.

The results of clinical trials show that people with abemaciclib who are on hormone therapy are more than 30% more likely that their cancer will not relapse after surgery than those who have only hormone therapy. rice field.

Abemaciclib, taken as a tablet twice daily, works by targeting and inhibiting proteins in cancer cells, allowing cancer to divide and grow.

Helen Knight, Interim Director of Drug Evaluation at NICE, said: The fact that we were able to develop draft recommendations very quickly is a testament to the success of our ambition to support patients’ access to clinical and cost-effective treatments as soon as possible. ..

“Until now, there was no cure for people with this type of breast cancer. Abemacyclib with hormone therapy is more likely to cure the disease because it offers targeted treatment early after surgery. , The treatment method is greatly improved because the possibility of developing intractable progressive disease is reduced. “

Sajid Javid, Minister of Health, said: “We are always looking for new and innovative cancer therapies. The UK has proven to be a pioneer in finding and deploying the world’s most groundbreaking medicines.

“This new drug means that thousands of breast cancer patients are more likely to recover from the disease and spend more valuable time with their loved ones.

“This is another great step forward in our ambition to make the UK one of the best countries in Europe in cancer treatment. This is my 10-year cancer plan announced this summer. It will be an important focus. “

NICE recommends Eli Lilly’s treatment for early-stage breast cancer

Source link NICE recommends Eli Lilly’s treatment for early-stage breast cancer

Related Articles

Back to top button